Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George P Kim

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
American Journal of Clinical Oncology|May 11, 2011
Gemcitabine and docetaxel for hepatocellular carcinoma: a phase II North Central Cancer Treatment Group clinical trialSteven R Alberts, Joel M Reid, Bruce W Morlan, et al.
The Oncologist|January 26, 2019
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)Thorvardur R Halfdanarson, Nathan R Foster, George P Kim, et al.
Clinical Colorectal Cancer|August 8, 2007
Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248Steven R Alberts, George P Kim, Michelle R Mahoney, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 6, 2011
Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinomaChakri Panjala, Justin H Nguyen, Ali N Al-Hajjaj, et al.
Journal of the National Cancer Institute|May 21, 2011
DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapyFrank A Sinicrope, Nathan R Foster, Stephen N Thibodeau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841George P Kim, Daniel J Sargent, Michelle R Mahoney, et al.
Gastrointestinal Cancer Research : GCR|November 1, 2012
A phase 2 trial of ixabepilone plus cetuximab in first-line treatment of metastatic pancreatic cancerCaio M Rocha Lima, Edward H Lin, George P Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005)Michele M Corsini, Robert C Miller, Michael G Haddock, et al.
Pharmacoeconomics|August 27, 2014
Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancerSteven R Alberts, Tiffany M Yu, Robert J Behrens, et al.
Investigational New Drugs|September 15, 2010
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinomaGeorge P Kim, Michelle R Mahoney, Daniel Szydlo, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
American Journal of Clinical Oncology|May 11, 2011
Gemcitabine and docetaxel for hepatocellular carcinoma: a phase II North Central Cancer Treatment Group clinical trialSteven R Alberts, Joel M Reid, Bruce W Morlan, et al.
The Oncologist|January 26, 2019
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)Thorvardur R Halfdanarson, Nathan R Foster, George P Kim, et al.
Clinical Colorectal Cancer|August 8, 2007
Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248Steven R Alberts, George P Kim, Michelle R Mahoney, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 6, 2011
Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinomaChakri Panjala, Justin H Nguyen, Ali N Al-Hajjaj, et al.
Journal of the National Cancer Institute|May 21, 2011
DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapyFrank A Sinicrope, Nathan R Foster, Stephen N Thibodeau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841George P Kim, Daniel J Sargent, Michelle R Mahoney, et al.
Gastrointestinal Cancer Research : GCR|November 1, 2012
A phase 2 trial of ixabepilone plus cetuximab in first-line treatment of metastatic pancreatic cancerCaio M Rocha Lima, Edward H Lin, George P Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005)Michele M Corsini, Robert C Miller, Michael G Haddock, et al.
Pharmacoeconomics|August 27, 2014
Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancerSteven R Alberts, Tiffany M Yu, Robert J Behrens, et al.
Investigational New Drugs|September 15, 2010
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinomaGeorge P Kim, Michelle R Mahoney, Daniel Szydlo, et al.
Pageof 5